Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
โ Scribed by C.A. Uyl-de Groot; J.B. Vermorken; M.G. Hanna Jr.; P. Verboom; M.T. Groot; G.J. Bonsel; C.J.L.M. Meijer; H.M. Pinedo
- Book ID
- 116957839
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 180 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Active specific immunotherapy (ASI) is a strategy that attempts to boost the host's immune response specifically against its own tumor. The purpose of this study was to investigate the effect of adjuvant AS1 in patients with renal carcinoma. ## METHODS. Of 120 consecutive patient
Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting al